共 50 条
- [41] Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer FRONTIERS IN ONCOLOGY, 2023, 13
- [42] Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review Advances in Therapy, 2021, 38 : 109 - 136
- [44] Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up Breast Cancer Research and Treatment, 2019, 174 : 719 - 729